Current results of the national breast cancer screening program in the Czech Republic;Aktuální výsledky mamografického screeningu v České Republice

Klinicka Onkologie

Volumn 20, Issue SUPPL., 2007, Pages 161-166

  Svobodnik A ^a   Danes J ^b   Skovajsova M ^c   Bartonkova H ^d   Klimes D ^a   Komolikova L ^a   Dusek L ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c Mammacentrum ^*  (Czech Republic)

^d MASARYK MEMORIAL CANCER INSTITUTE   (Czech Republic)

Author keywords

Effectiveness evaluation and breast cancer; Mammography; Screening

Indexed keywords

ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; CZECH REPUBLIC; EVALUATION; HUMAN; MAMMOGRAPHY; WOMEN'S HEALTH;

EID: 33947588128     PISSN: 0862495X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Botha JL, Bray F, Sankila R et al.: Breast cancer incidence and mortality trends in 16 European countries. Eur J Cancer. 2003 Aug;39(12):1718-29.
2. Shapiro S, Coleman EA, Broeders M et al.: Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. International Breast Cancer Screening Network (IBSN) and the European Network of Pilot Projects for Brest Cancer Screening. Int J Epidemiol. 1998 Oct;27(5):735-42.
3. Feuer, EJ, Wun LM.: How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization? A dynamic population model approach. Am J Epidemiol. 1992 Dec 15;136(12):1423-36.
4. Oluwole SF, Ali AO, Adu A. et al.: Impact of a Cancer Screening Program on Brest Cancer Stage at Diagnosis in a Medically Underserved Urban community. J Am Coll Surg 2003; 196:180-188.
5. Jatoi I, Miller AB.: Why is breast-cancer mortality declining? Lancet Oncol. 2003 Apr;4(4):251-4.
6. Early Breast Cancer Trialists Collaborative Group: Polychemotherapy for early Brest cancer: an overview of the randomised trials. Lancet. 1998 Sep 19;352(9132):930-42.
7. Blanks RG, Moss SM, McGahan CE et al.: Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ 2000; 321:665-669.
8. Moss SM, Summerley ME, Thomas BT,: A case-control evaluation of the effect of breast cancer screening in the United Kingdom trial of early detection of breast cancer. J Epidemiol Community Health. 1992 Aug;46(4):362-4.
9. De Koning HJ: Why improvement in survival of screen-detected cases is not necessarily equivalent to benefit? Breast 2003:12,299-301.
10. Shapiro S, Strax P, Venet L.: Evaluation of periodic breast cancer screening with mammography. Methodology and early observations. JAMA 1966; 195:731-738.
11. Alexander FE, Anderson TJ, Brown HK et al.: The Edinburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br J Cancer 1994;70:542-548.
12. Andersson I, Aspegren K, Janzon L et al.: Mammographic screening and mortality from breast cancer: the Malmo mammographic screening trial. BMJ. 1988 Oct 15;297(6654):943-8.
13. Tabar L, Fagerberg CJ, Gad A et al.: Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-832.
14. Frisell J, Glas U, Hellstrom L et al.: Randomized mammographic screening for Brest cancer in Stockholm. Design, first round results and comparisons. Breast Cancer Res Treat 1986;8:45-54.
15. Bjurstam N, Bjorneld L, Duffy SW et al.: The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization. Cancer 1997;80:2091-2099.
16. Nystrom L, Rutqvist LE, Wall S et al.: Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet. 1993 Aprl7;341(8851):973-8.
17. Miller AB, Baines CJ, To T et al.: Canadian National Breast Screening Study I. Brest cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J. 1992a; 147:1459-1476.
18. Miller AB, Baines CJ, To T et al.: Canadian National Breast Screening Study I. Brest cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J. 1992b;147.1477-1488.
19. Miller AB, To T, Baines CJ et al.: Canadian National Breast Cancer Screening Study-2: 13 years results of a randomized trial in women aged 50-59 years. J Natl Cancer Inst 2000; 92: 1490-1499.
20. Shapiro S: Periodic screening for breast cancer: the HIP Randomized controlled Trial. J Natl Cancer Inst Monogr 1997; 22: 27-30.
21. Tabar L, Vitak B, Chen HH et al.: The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin. North Am 2000; 38: 625-651.
22. Jatoi I.: Breast cancer screening. Am J Surg. 1999 Jun; 177(6):518-24.
23. Kerlikowske K, Grady D, Rubin SM: Efficacy of screening mammography. A meta analysis. JAMA. 1995 Jan 11;273(2):149-54.
24. Gøtzsche PC, Olsen O: Is screening for breast cancer with mammography justifiable? Lancet 2000; 355: 129-134.
25. Boyle P.: Current situation of screening for cancer. Ann Oncol 2002; 13: 189-198.
26. Olsen O, Gøtzsche PC: Screening for breast cancer with mammography. Cochrane Database SystRev. 2001 ;(4):CD001877.
27. Olsen O, Gøtzsche PC: Cochrane review on screening for breast cancer with mammography. Lancet. 2001b Oct 20;358(9290): 1340-2.
28. Olsen O, Gøtzsche PC: Systematic review of screening for breast can cer with mammography. 2001c. http://image.thelancet.com/lancet/extra/ fullreport.pdf (navštiveno 30. 1. 2003).
29. Otto SJ, Fracheboud J, Looman CW et al.: Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet. 2003 Apr 26;361(9367):1411-7.
30. Jørgensen KJ, Gøtzsche PC: Presentation on websites of possible benefits and harms from screening for breast cancer: cross sectional study. BMJ. 2004 Jan 17;328(7432):148.
31. Tabar L, Yen MF, Vitak B et al.: Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet. 2003 Apr 26;361(9367):1405-10.
32. Klemi PJ, Joensuu H, Toikkanen S, et al.: Aggressiveness of breast cancers found with and without screening. BMJ. 1992 Feb 22;304(6825):467-9.
33. Jatoi I, Baum M.: American and European recommendations for screening mammography in younger women: a cultural divide? BMJ. 1993 Dec 4;307(6917):1481-3.
34. Jonsson H, Nyström L, Tornberg B et al.: Service screening with mam̈ mography. Long term effects on breast cancer mortality in the county of Gävleborg, Sweden. Breast 2003: 12; 183-193.
35. Black WC, Haggstrom DA, Welch HG.: All-cause mortality in randomized trials of cancer screening. J Natl Cancer Inst 2002; 94: 167-173.
36. Buiatti E, Barchielli A, Bartolacci S: The impact of organised screening programmes on the stage-specific incidence of breast cancer in some Italian areas. Eur J Cancer. 2003 Aug;39( 12): 1776-82.
37. Sant M, Allemani K, Capocaccia R. et al.: Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer: 106, 416-422 (2003).
38. Tolma EL, Reininger BM, Ureda J et al.: Cognitive motivations associated with screening mammmography in Cyprus. Prev Med. 2003 Mar;36(3):363-73.
39. Humphrey LL, Helfand M, Chan BK et al.: Breast cancer screening: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002; 137:347 360.
40. Black WC, Nease RF, Tosteson ANA: Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age. J Natl Cancer Inst. 1995;87:720-731.
41. Slaytor EK, Ward JE: How risk of breast cancer and benefits of screening are communicated to women: analysis of 58 pamphlets. BMJ. 1998 Jul 25;317(7153):263-4.
42. Raffle AE: Information about screening - is it to achieve high uptake or to ensure informed choice? Health Expect. 2001 Jun;4(2):92-8.
43. Croft E, Barratt A, Butow P: Information about tests for breast cancer: what are we telling people? J Fam Pract. 2002 Oct;51(10):858-60.
44. Semiglazov VF, Moiseyenko VM, Bavli JL et al.: The role of breast self-examination in early breast cancer detection (results of the 5-years USSR/WHO randomized study in Leningrad). Eur J Epidemiol. 1992 Jul;8(4):498-502.
45. Thomas DB, Gao DL, Self SG et al.: Randomized trial of breast self-examination in Shanghai: methodology and preliminary results. J Natl Cancer Inst. 1997 March 5;89(5):355-65.
46. Kotalik JF, Holloway G, Woodbeck H: The creation of a database for cancer screening: is the consent of clients required? Cancer Prev Control. 1999 Apr;3(2):119, 24.
47. Nottingham J.: Informed consent. Screening programmes need consent forms. BMJ. 1998 Oct 3;317(7163):948-9.
48. European Opinion Research Group. European Union citizens and sources of information About health. 2003.http://europa.eu.int/comm/health/ph_information/ documents/eb_58_en.pdf (navštíveno 30.1.2003).
49. Bekelman JE, Li Y, gross CP: Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA. 2003 Jan 22-29;289(4):454-65.
50. Lexchin J, Bero LA, Djulbegovic B et al.: Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ. 2003 May 31;326(7400):1167, 70.
51. Beemsterboer PM, Warmerdam PG, Boer R, et al.: Radiation risk of mammography related to benefit in screening programmes: a favourable balance? J Med Screen. 1998;5(2):81-7.
52. Elmore JG, Barton MB, Moceri VM et al.: Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998 Apr 16;338(16):1089-96.
53. Elwood M, McNoe B, Smith T: Once is enough - why some women do not continue to participate in a breast cancer screening programme. N Z Med J. 1998 May 22;111(1066):180-3.
54. Miller AB: The costs and benefits of breast cancer screening. Am J Prev Med. 1993 May-Jun;9(3):175-80.
55. Yen MF, Tabar L, Vitak B: Quantifying the potential problem of over-diagnosis of ductal carcinoma in situ in breast cancer screening. Eur J Cancer. 2003 Aug;39(12):1746-54.
56. Peeters PHM, Verbeek ALM, Straatman H et al.: Evaluation of over-diagnosis of breast cancer in screening with mammography: results of Nijmagen programme. Int J Epidemiol 1989; 18:295-299.
57. Ernster VL, Barclay J, Kerlikowske K et al.: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913-918.